Patents by Inventor Michael McVoy

Michael McVoy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HUMAN CYTOMEGALOVIRUS VACCINE
    Publication number: 20150086578
    Abstract: Combination peptides, polypeptides and proteins that elicit high titer neutralizing antibodies against cytomegalovirus (CMV) are provided. The combination peptides, polypeptides and proteins encompass epitopes located within the UL130 and UL131 components of the gH/gL/UL128-131 protein complex, in particular, epitopes located within amino acid residues 27-46 of UL130 and amino acid residues 90-106 of UL131. The combination peptides, polypeptides and proteins, and the nucleic acids encoding them, may be used in vaccines, and as diagnostic and research tools.
    Type: Application
    Filed: August 25, 2014
    Publication date: March 26, 2015
    Applicant: VIRGINIA COMMONWEALTH UNIVERSITY
    Inventors: Michael McVoy, Stuart Adler, Xiaohong Cui
  • HUMAN CYTOMEGALOVIRUS VACCINE
    Publication number: 20130164289
    Abstract: Combination peptides, polypeptides and proteins that elicit high titer neutralizing antibodies against cytomegalovirus (CMV) are provided. The combination peptides, polypeptides and proteins encompass epitopes located within the UL130 and UL131 components of the gH/gL/UL128-131 protein complex, in particular, epitopes located within amino acid residues 27-46 of UL130 and amino acid residues 90-106 of UL131. The combination peptides, polypeptides and proteins, and the nucleic acids encoding them, may be used in vaccines, and as diagnostic and research tools.
    Type: Application
    Filed: September 9, 2011
    Publication date: June 27, 2013
    Applicant: Virginia Commonwealth University
    Inventors: Michael McVoy, Stuart Adler, Xiaohong Cui